Loading clinical trials...
Loading clinical trials...
A Controlled, Assessor-blind, Parallel Groups, Multicentre, Multinational Trial Evaluating the Immunogenicity of FE 999049 in Repeated Cycles of Controlled Ovarian Stimulation in Women Undergoing an Assisted Reproductive Technology Programme
Conditions
Interventions
Follitropin Delta (FE 999049)
Follitropin Alfa (GONAL-F)
Locations
13
Belgium
UZ Brussel (there may be other sites in this country)
Brussels, Belgium
Fertilitat and PUC-RS (there may be other sites in this country)
Porto Alegre, Brazil
Pacific Centre for Reproductive Medicine
Burnaby, British Columbia, Canada
Olive Fertility Centre
Vancouver, British Columbia, Canada
Ottawa Fertility Centre
Ottawa, Ontario, Canada
IVF CUBE SE (there may be other sites in this country)
Prague, Czechia
Start Date
March 26, 2014
Primary Completion Date
May 1, 2015
Completion Date
January 3, 2017
Last Updated
September 6, 2023
NCT06826365
NCT07153367
NCT07462065
NCT04872660
NCT05903859
NCT06742437
Lead Sponsor
Ferring Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions